Overview of Dr. Barbieri
Dr. Christopher Barbieri is an urologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 10 years. He is one of 188 doctors at New York-Presbyterian Hospital and one of 62 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Urology. He has more than 100 publications and over 500 citings.
Office
535 E 68th St
New York, NY 10065
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 2009 - 2013- New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 2007 - 2009
Vanderbilt University School of MedicineClass of 2007
Certifications & Licensure
NY State Medical License 2009 - 2026- American Board of Urology Urology
Awards, Honors, & Recognition
- MetLife Clinical Investigator Award Damon Runyon Cancer Research Foundation, 2016
- Rising Star in Urology Research Urology Care Foundation / AUA, 2015
- Challenge Award Prostate Cancer Foundation, 2014
- Join now to see all
Publications & Presentations
PubMed
- 2101 citationsThe Molecular Taxonomy of Primary Prostate CancerAdam Abeshouse, Jaeil Ahn, Rehan Akbani, Adrian Ally, Samirkumar B. Amin
Cell. 2015-11-05 - 8 citationsCHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis.Michael A Augello, Deli Liu, Lesa D Deonarine, Brian D Robinson, Dennis Huang
Cancer Cell. 2019-05-13 - 1131 citationsExome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancerChristopher E. Barbieri, Sylvan C. Baca, Michael S. Lawrence, Francesca Demichelis, Mirjam Blattner
Nature Genetics. 2012-06-01
Journal Articles
- Impact of Pelvic Radiation Therapy on Inflatable Penile Prosthesis Reoperation RatesChristopher E Barbieri, James A Kashanian, The Journal of Sexual Medicine
- Introduction to “Molecular Drivers of Prostate Cancer Development, Progression, and Resistance to Therapy”Christopher Barbieri, MD, Urologic Oncology
- Molecular Subtypes of Prostate CancerChristopher Barbieri, MD, Current Oncology Reports
Authored Content
- SPOP Mutated/ CHD1 Deleted Lethal Prostate Cancer and Abiraterone SensitivityMarch 2018
Press Mentions
What You Need to Know About Prostate Cancer TreatmentsOctober 7th, 2024- Prostate Cancer’s Spread Modeled with CRISPR Barcoding TechnologySeptember 23rd, 2024
- Study Zeros in on Why Men Abandon Prostate Cancer Active SurveillanceOctober 25th, 2021
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
